These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13922689)

  • 1. Decarboxylase inhibitors affect convulsion thresholds to hexafluorodiethyl ether.
    TRUITT EB; EBERSBERGER EM
    Science; 1962 Jan; 135(3498):105-6. PubMed ID: 13922689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacological actions of 3,4-dihydroxyphenyl-alpha-methylalanine (alpha-methyldopa), an inhibitor of 5-hydroxytryptophan decarboxylase.
    SMITH SE
    Br J Pharmacol Chemother; 1960 Jun; 15(2):319-27. PubMed ID: 13832156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of the decarboxylase inhibitor, alpha-methyl-3,4-dihydroxyphenylalanine, in the dog.
    GOLDBERG LI; DACOSTA FM; OZAKI M
    Nature; 1960 Nov; 188():502-4. PubMed ID: 13706461
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of reserpine and other agents upon leptazol convulsions in mice.
    LESSIN AW; PARKES MW
    Br J Pharmacol Chemother; 1959 Mar; 14(1):108-11. PubMed ID: 13651586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of a new decarboxylase inhibitor on endogenous monoamines.
    PLETSCHER A; GEY KF
    Biochem Pharmacol; 1963 Mar; 12():223-8. PubMed ID: 13944044
    [No Abstract]   [Full Text] [Related]  

  • 8. Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain.
    KUNTZMAN R; SHORE PA; BOGDANSKI D; BRODIE BB
    J Neurochem; 1961 Feb; 6():226-32. PubMed ID: 13755185
    [No Abstract]   [Full Text] [Related]  

  • 9. CENTRAL STIMULANT ACTIONS OF ALPHA-ALKYL SUBSTITUTED TRYPTAMINES IN MICE.
    LESSIN AW; LONG RF; PARKES MW
    Br J Pharmacol Chemother; 1965 Feb; 24(1):49-67. PubMed ID: 14301999
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamines and their metabolites in the avian brain.
    Juorio AV; Vogt M
    J Physiol; 1967 Apr; 189(3):489-518. PubMed ID: 6040158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ROLE OF SEVERAL SEROTONIN AND CATECHOLAMINE LIBERATORS IN THE PHENOMENON OF PAIN IN THE RAT].
    GASCON A
    Rev Can Biol; 1964 Jun; 23():169-86. PubMed ID: 14221453
    [No Abstract]   [Full Text] [Related]  

  • 12. INHIBITION OF CEREBRAL DECARBOXYLASE AND BEHAVIOUR.
    PLETSCHER A; PRADAM DA; STEINER FA
    Int J Neuropharmacol; 1964 Dec; 3():550-64. PubMed ID: 14344493
    [No Abstract]   [Full Text] [Related]  

  • 13. Decarboxylase inhibition and blood pressure reduction by alpha-methyl-3,4-dihydroxy-DL-phenylalanine.
    OATES JA; GILLESPIE L; UDENFRIEND S; SJOERDSMA A
    Science; 1960 Jun; 131(3417):1890-1. PubMed ID: 14428139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of intravenously administered DOPA on the blood pressure in pretreated alpha-methyl-DOPA hypertensives. Studies on the blood pressure-lowering mechanism of alpha-methyl-DOPA].
    SCHAER H; ZIEGLER WH
    Klin Wochenschr; 1962 Sep; 40():959-62. PubMed ID: 13976633
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of stress-induced histidine decarboxylase to circulatory homeostasis and shock.
    SCHAYER RW
    Science; 1960 Jan; 131(3395):226-7. PubMed ID: 14442503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain amines and electroshock threshold.
    DE SCHAEPDRYVER AF; PIETTE Y; DELAUNOIS AL
    Arch Int Pharmacodyn Ther; 1962 Dec; 140():358-67. PubMed ID: 14026056
    [No Abstract]   [Full Text] [Related]  

  • 17. Competitive inhibition of 3, 4-dihydroxyphenylalanine (DOPA) decarboxylase in vitro.
    HARTMAN WJ; AKAWIE RI; CLARK WG
    J Biol Chem; 1955 Oct; 216(2):507-29. PubMed ID: 13271331
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine.
    Carlsson A
    Adv Biochem Psychopharmacol; 1974; 10():75-81. PubMed ID: 4152552
    [No Abstract]   [Full Text] [Related]  

  • 19. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 20. A rapid method for the determination of dihydroxyphenylalanine decarboxylase in animal tissues.
    DIETRICH LS
    J Biol Chem; 1953 Oct; 204(2):587-91. PubMed ID: 13117832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.